Funded Tech Companies

Seres Therapeutics

Operating out of Cambridge, Seres Therapeutics has funding from private investors, Mayo Medical Ventures and Alexandria Venture Investments.

Company Overview

Company Name
Seres Therapeutics
Company Status
Publicly-held
Funding Rounds

Contact Information

Mailing Address
200 Sidney St.
Cambridge, MA 02139
USA
Email Address

Company Background Information

Overview
Seres Therapeutics (NASDAQ: MCRB) is creating a new class of medicines to treat diseases resulting from functional deficiencies in the microbiome, a condition known as dysbiosis.
Profile
Seres Therapeutics LinkedIn Company Profile
Social Media
Seres Therapeutics Company Twitter Account
Company News
Seres Therapeutics News
Facebook
Seres Therapeutics on Facebook
YouTube
Seres Therapeutics on YouTube
Last Transaction
6/26/2015

Financing History

Date
Type
Amount
IPO
$133,200,000
Venture Equity
$64,999,998
Venture Equity
$47,999,977
Venture Equity
$10,000,000
Venture Equity
$10,500,000


Management Team

Title
Name
Email & Social
Chief Executive Officer
Roger Pomerantz
  Roger Pomerantz LinkedIn Profile  Roger Pomerantz Twitter Account  Roger Pomerantz News  Roger Pomerantz on Facebook
Chief Financial Officer
Eric Shaff
  Eric Shaff LinkedIn Profile  Eric Shaff Twitter Account  Eric Shaff News  Eric Shaff on Facebook
Chief Medical Officer
Michele Trucksis
  Michele Trucksis LinkedIn Profile  Michele Trucksis Twitter Account  Michele Trucksis News  Michele Trucksis on Facebook
Chief Scientific Officer
David Cook
  David Cook LinkedIn Profile  David Cook Twitter Account  David Cook News  David Cook on Facebook
Chief Technical Officer
John Aunins
  John Aunins LinkedIn Profile  John Aunins Twitter Account  John Aunins News  John Aunins on Facebook
VP - Bus. Development
Henry Rath
  Henry Rath LinkedIn Profile  Henry Rath Twitter Account  Henry Rath News  Henry Rath on Facebook
VP - General Counsel
Thomas DesRosier
  Thomas DesRosier LinkedIn Profile  Thomas DesRosier Twitter Account  Thomas DesRosier News  Thomas DesRosier on Facebook
VP - Operations
Carol Cullinan
  Carol Cullinan LinkedIn Profile  Carol Cullinan Twitter Account  Carol Cullinan News  Carol Cullinan on Facebook
VP - R & D
Matthew Henn
  Matthew Henn LinkedIn Profile  Matthew Henn Twitter Account  Matthew Henn News  Matthew Henn on Facebook
VP - Regulatory Affairs
Barbara McGovern
  Barbara McGovern LinkedIn Profile  Barbara McGovern Twitter Account  Barbara McGovern News  Barbara McGovern on Facebook


Company Investors

 

 

 

Browse more funded tech companies:

Serenity Kids | SERG Technologies

 

Share this article

 


About Our Venture Capital Database

This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary